TABLE 1.
Serotype | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COVID‐19 patients (n = 190) | HKCCBR (n = 3892) | HKRCBTS blood donors (n = 294) | ||||||||||||
Count | Frequency | Count* | Frequency | OR | 95% CI | p‐value | Corrected p‐value | Count | Frequency | OR | 95% CI | p‐value | Corrected p‐value | |
B5 | 15 | 3.95% | 520 | 6.68% | 0.57 | 0.34–0.97 | 0.033 | ns | 26 | 4.42% | / | / | 0.870 | / |
B7 | 8 | 2.11% | 123 | 1.58% | / | / | 0.400 | / | 9 | 1.53% | / | / | 0.618 | / |
B8 | 1 | 0.26% | 23 | 0.30% | / | / | 1.000 | / | 1 | 0.17% | / | / | 1.000 | / |
B12 | 1 | 0.26% | 143 | 1.84% | 0.14 | 0.02–1.01 | 0.015 | ns | 5 | 0.85% | / | / | 0.413 | / |
B13 | 38 | 10.00% | 733 | 9.42% | / | / | 0.719 | / | 59 | 10.03% | / | / | 1.000 | / |
B15 | 69 | 18.16% | 1217 | 15.63% | / | / | 0.194 | / | 108 | 18.37% | / | / | 1.000 | / |
B16 | 22 | 5.79% | 556 | 7.14% | / | / | 0.357 | / | 44 | 7.48% | / | / | 0.361 | / |
B17 | 30 | 7.89% | 673 | 8.65% | / | / | 0.708 | / | 46 | 7.82% | / | / | 1.000 | / |
B22 | 43 | 11.32% | 540 | 6.94% | 1.71 | 1.23–2.38 | 0.002 | 0.032 | 42 | 7.14% | 1.66 | 1.06–2.59 | 0.027 | ns |
B27 | 4 | 1.05% | 202 | 2.60% | / | / | 0.064 | / | 18 | 3.06% | 0.34 | 0.11–1.00 | 0.047 | ns |
B35 | 13 | 3.42% | 259 | 3.33% | / | / | 0.883 | / | 19 | 3.23% | / | / | 0.856 | / |
B40 | 73 | 19.21% | 1416 | 18.19% | / | / | 0.634 | / | 105 | 17.86% | / | / | 0.611 | / |
B46 | 56 | 14.74% | 1090 | 14.00% | / | / | 0.705 | / | 85 | 14.46% | / | / | 0.926 | / |
B48 | 6 | 1.58% | 147 | 1.89% | / | / | 0.846 | / | 11 | 1.87% | / | / | 0.807 | / |
B67 | 1 | 0.26% | 14 | 0.18% | / | / | 0.511 | / | 1 | 0.17% | / | / | 1.000 | / |
Abbreviations: n, number of subjects; OR, Odds ratio; 95% CI, 95% confidence interval; corrected p value, p value after Bonferroni correction.
All the HLA‐B alleles belonging to the same serotype were counted.